TABLE 1.
Variables | Zoledronic Acid Interval Dosing | |
---|---|---|
| ||
Standard (n = 121) | Extended (n = 35) | |
Age, mean (SD), y | 69 (10) | 68 (10) |
| ||
Race, No. (%) | ||
White | 45 (37) | 10 (29) |
African American | 75 (62) | 25 (71) |
Other | 1 (1) | 0 (0) |
| ||
Sex, No. (%) | ||
Male | 118 (98) | 34 (97) |
Female | 3 (2) | 1 (3) |
| ||
Malignancy, No. (%) | ||
Multiple myeloma | 21 (7) | 7 (20) |
Prostate cancer | 100 (83) | 28 (80) |
| ||
Dental screening, No. (%) | ||
Before | 17 (14) | 6 (17) |
During | 21 (17) | 7 (20) |